The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Summary

OCID:: ocds-kuma6s-125696
Published by:: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Authority ID:: AA0221
Publication date:: 10 July 2024
Deadline date:: -
Notice type:: 03 Contract Award Notice - Successful Supplier(s)
Has documents:: No
Has SPD:: No
Has Carbon Reduction Plan:: No

Abstract

NHS Procurement Wales, on behalf of the Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Rapid Diagnosis Clinics (RDC) programme. Evaluation is an integral part of the work we do within the Wales Cancer Network, and we use findings to facilitate learning, drive service improvement, inform future programme development, and guide decision-making. We are committed to assessing whether we have achieved our objectives and the processes which led to success (or not). The RDC programme is a national initiative supporting Health Boards in Wales to provide General Practitioners (GPs) with a referral pathway and RDC to investigate vague symptoms that may be caused by cancer. The programme commenced in December 2020 and is due to complete in March 2023. A Rapid Diagnosis Clinic (RDC) provides a diagnostic route for patients with non-specific but concerning (vague) symptoms who do not fit into a standard Suspected Cancer Pathway, because of the absence of clear ‘red flag’ symptoms. RDCs aims to: - Support earlier diagnosis for patients with vague, non-specific symptoms that could be cancer - Reduce cancer diagnoses via emergency presentations - Improve overall patient health outcomes by detecting cancer earlier - Improve patient and GP experience - Identify and manage other serious non-malignant disease or those at risk of developing serious illness The aim of the evaluation is to provide an independent assessment of the RDC programme and deliverables to: - communicate the impact, value and learning - inform Health Board sustainability plans for RDCs across Wales - inform future developments and programme approaches within the Wales Cancer Network CPV: 79419000, 79419000.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

NHS Wales Shared Services Partnership

2nd Floor Woodland House, Maes-y-Coed Road

Cardiff

CF14 4TT

Telephone: +44 2921508271

E-mail: Owen.rees3@wales.nhs.uk

NUTS: UK

Internet address(es)

Main address: http://www.procurement.wales.nhs.uk

Address of the buyer profile: http://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.4) Type of the contracting authority

Regional or local authority

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Consultancy work in relation to the evaluation of the all-Wales Rapid Diagnosis Clinics Programme

Reference number: CAV-ITT-PROJECT40225

II.1.2) Main CPV code

79419000

II.1.3) Type of contract

Services

II.1.4) Short description

NHS Procurement Wales, on behalf of the Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Rapid Diagnosis Clinics (RDC) programme.

Evaluation is an integral part of the work we do within the Wales Cancer Network, and we use findings to facilitate learning, drive service improvement, inform future programme development, and guide decision-making. We are committed to assessing whether we have achieved our objectives and the processes which led to success (or not).

The RDC programme is a national initiative supporting Health Boards in Wales to provide General Practitioners (GPs) with a referral pathway and RDC to investigate vague symptoms that may be caused by cancer. The programme commenced in December 2020 and is due to complete in March 2023. A Rapid Diagnosis Clinic (RDC) provides a diagnostic route for patients with non-specific but concerning (vague) symptoms who do not fit into a standard Suspected Cancer Pathway, because of the absence of clear ‘red flag’ symptoms. RDCs aims to:

- Support earlier diagnosis for patients with vague, non-specific symptoms that could be cancer

- Reduce cancer diagnoses via emergency presentations

- Improve overall patient health outcomes by detecting cancer earlier

- Improve patient and GP experience

- Identify and manage other serious non-malignant disease or those at risk of developing serious illness

The aim of the evaluation is to provide an independent assessment of the RDC programme and deliverables to:

- communicate the impact, value and learning

- inform Health Board sustainability plans for RDCs across Wales

- inform future developments and programme approaches within the Wales Cancer Network

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 45 180.00 GBP

II.2) Description

II.2.2) Additional CPV code(s)

79419000

II.2.3) Place of performance

NUTS code:

UKL22

Main site or place of performance:

NHS Collaborative - Cardiff

II.2.4) Description of the procurement

NHS Procurement Wales, on behalf of the Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Rapid Diagnosis Clinics (RDC) programme.

Aim:

- to support the implementation and sustainability of an RDC Service in all Welsh Health Boards, using a nationally coordinated, locally implemented programme approach

Objectives:

- to provide the necessary tools and evidence to deliver a high quality and person-centred service to patients with vague symptoms suspicious of cancer

- to develop and deliver educational resources to support the learning and sharing of good practice between Health Board RDC models

The aim of the evaluation is to provide an independent assessment of the RDC programme and deliverables to:

- communicate the impact, value and learning

- inform Health Board sustainability plans for RDCs across Wales

- inform future developments and programme approaches within the Wales Cancer Network

II.2.5) Award criteria

Quality criterion: Quality / Weighting: 70%

Price / Weighting: 30%

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2022/S 000-029194

Section V: Award of contract

Contract No: CAV-ITT-PROJECT52024

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

01/02/2023

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 1

Number of tenders received from tenderers from EU Member States: 0

Number of tenders received from tenderers from non-EU Member States: 1

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

MEL Research

Somerset House, 37 Temple Street

Birmingham

B25DP

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 45 180.00 GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

This notice refers to a contract that was awarded on 01/02/2023 and has been completed.

(WA Ref:142899)

VI.4) Procedures for review

VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL